"Uttar Pradesh contributes about 15 per cent of the total pharmaceutical market and is a significant area for us. We will be catering to whole of the state through our distribution network of wholesalers and depot operations," Ashwin Kapur, executive director ALPL told Business Standard. The company has launched 15 products currently and plans to introduce 5 more in the next one month.
"When we thought of diversification, automobiles, Information technology and pharmaceuticals seem to be the promising sectors. However we settled for pharma as it is growing on an average of 14 per cent presently. We will bring 20 more products within a year," Kapur added.
ALPL has set up state of the art manufacturing plant at Haridwar, Uttarakhand.
Disclosing the expansion plans Kapur said, "Ours is one of the largest integrated plants in Northern India, which provides almost all facilities under one roof. We have already invested over 100 crores in this plant and a further investment to the tune of 400-500 crores is in the pipeline," Kapur informed.
The company is targeting a turnover of 500 crores in the next five years.
After completing phase-I, i.e. North India, the company will enter other parts of the country in Phase-II.
"Our target is to have a network of over 1000 dealers (1 Lac retail outlets) all across the country in the next 18 months. In North India we intend appointing 250 dealers (30000 retail outlets) to market our products," he said.
The company is also looking to tap the export opportunities in a big way.
"We will initially look at African, Russian and Middle East countries for exporting purposes, later venturing into European and American market" he said.
